Resultados de la búsqueda 1301-1310 of 10825 for Lupus

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive ...

  2. Neurocirugía - Ensayos clínicos

    The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall ...

  3. Ensayos clínicos - Neurología

    Jacksonville, Fla. The purpose of this study is to evaluate plasma biomarkers of vascular function and inflammation in patients with newly-diagnosed Obstructive ...

  4. Hematología - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

  5. Ensayos clínicos - Neurocirugía

    The purpose of this study is to evaluate the safety and feasibility of intra-operative microperfusion during a planned neurosurgical resection of diseased ...

  6. Síndrome de Sézary - Diagnósticos y tratamientos - Mayo Clinic

    Este medicamento daña las células cancerosas. Luego, la máquina devuelve la sangre tratada al cuerpo. Este proceso ayuda al sistema inmunitario a reconocer y ...

  7. Cirugía - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to evaluate thymoma recurrence rates in patients who underwent thymectomy. 3D Ultrasound Imaging for Breast Cancer ...

  8. Vasculitis - Médicos y departamentos - Mayo Clinic

    Lupus, Dermatomiositis, Morfea, Psoriasis, Vasculitis, Eritema multiforme. Lindsy N. Williams, M.D.. neurólogo. Jacksonville, FL. Áreas ...

  9. Ensayos clínicos - Neurocirugía

    The purpose of this study is to evaluate the safety and feasibility of intra-operative microperfusion during a planned neurosurgical resection of diseased ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...